Search Results - "Collinge, Janine E."

Outcome of pediatric patients referred for papilledema by Kovarik, Jessica J., MD, Doshi, Poonam N., MD, Collinge, Janine E., MD, Plager, David A., MD

“…Purpose To determine the prevalence of papilledema versus pseudopapilledema among children referred for suspected papilledema and to identify clinical factors…”
Get full text

Update in pediatric optic neuritis by Collinge, Janine E, Sprunger, Derek T

“…PURPOSE OF REVIEWPediatric optic neuritis is an uncommon disorder with significant distinctions from its adult counterpart. Recognizing the features of this…”
Get full text

Struggling resident surgeons: educational strategies for success by Siatkowski, R. Michael, Yanovitch, Tammy L, Collinge, Janine E, Motley, W. Walker, Quinn, Graham

Get full text

Outcome of pediatric patients referred for papilledema by Kovarik, Jessica J, Doshi, Poonam N, Collinge, Janine E, Plager, David A

Get full text

Expression of tissue plasminogen activator during eye development by Collinge, Janine E., Simirskii, Vladimir N., Duncan, Melinda K.

“…Tissue plasminogen activator (tPA) is a serine protease responsible for the activation of plasminogen to plasmin as well as extracellular matrix remodeling…”
Get full text

Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes by Freedman, Sharon F., Hercinovic, Amra, Wallace, David K., Kraker, Raymond T., Li, Zhuokai, Bhatt, Amit R., Boente, Charline S., Crouch, Eric R., Hubbard, G. Baker, Rogers, David L., VanderVeen, Deborah, Yang, Michael B., Cheung, Nathan L., Cotter, Susan A., Holmes, Jonathan M.

“…Low-dose and very low-dose intravitreal bevacizumab (IVB) have been reported successful in short-term treatment of type 1 retinopathy of prematurity (ROP),…”
Get full text

The Pediatric Optic Neuritis Prospective Outcomes Study: Two-Year Results by Pineles, Stacy L, Henderson, Robert J, Repka, Michael X, Heidary, Gena, Liu, Grant T, Waldman, Amy T, Borchert, Mark S, Khanna, Sangeeta, Graves, Jennifer S, Collinge, Janine E, Conley, Julie A, Davis, Patricia L, Kraker, Raymond T, Cotter, Susan A, Holmes, Jonathan M

“…Pediatric optic neuritis (ON) is a rare disease that has not been well characterized. The Pediatric ON Prospective Outcomes Study (PON1) was the first…”
Get full text

Choice of Dose Level for a Randomized Clinical Trial of Low-Dose Bevacizumab vs Laser for Type 1 Retinopathy of Prematurity by Kraker, Raymond T, Wallace, David K, Beck, Roy W, Saunders, Christina T, Lorenzi, Elizabeth, Melia, B Michele, Li, Zhuokai

Get more information

Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity by Freedman, Sharon F., Hercinovic, Amra, Wallace, David K., Kraker, Raymond T., Li, Zhuokai, Bhatt, Amit R., Boente, Charline S., Crouch, Eric R., Hubbard, G. Baker, Rogers, David L., VanderVeen, Deborah, Yang, Michael B., Cheung, Nathan L., Cotter, Susan A., Holmes, Jonathan M., Prakalapakorn, Sasapin G., Jones, Sarah K., Barman, Navajyoti R., House, Robert J., Nasrazadani, David A., Crouch, Eric, Crouch, Earl R., Ventura, Gaylord G., Dosunmu, Eniolami O., Gray, Michael E., Motley, William W., Castleberry, Katherine, Cobb, Patricia, Hirsch, Patricia, Reed, Melissa, Sandoval, Monica A., Vallabh, Neil, Bremer, Don.L., Golden, Richard P., Jordan, Catherine O., McGregor, Mary Lou, Reem, Rachel E., Schreckengost, Amanda N., Maletic, Sara A., Miller, Rachel T., Coats, David K., Romany, Gihan, Demmy, Ann B., Kong, Lingkun X., Hartnett, Mary E., Dries, David C., Hoffman, Robert O., Allman, Susan, Farnsworth, Katie J., Hart, Barbara, Ordonez, Kelliann, Hutchinson, Amy K., Hubbard, George B., Rao, Prethy, Robinson, Joshua E., Brower, Judy L., Haider, Kathryn M., Smith, Heather A., Hynes, Elizabeth A., Whitaker, Michele E., VanderVeen, Deborah K., Mantagos, Jason S., Wu, Carolyn, Goldstein, Samantha, Winter, Tamar, Yoon, Grace X., Siatkowski, R. Michael, Collinge, Janine E., Satnes, Kelli J., Blunt, Michelle H., Repka, Michael X., Kraus, Courtney, Shepard, Jennifer A., Beck, Roy W., Austin, Darrell S., Boyle, Nicole M., Chandler, Danielle L., Connelly, Patricia L., Conner, Courtney L., Donahue, Quayleen, Fimbel, Brooke P., Henderson, Robert J., Hoepner, James E., Kaplon, Joseph D., Melia, B. Michele, Ortiz, Gillaine, Robinson, Julianne L., Stutz, Kathleen M., Sutherland, Desirae R., Toro, David O., Woodard, Victoria C., Wu, Rui, Birch, Eileen E., Chen, Angela M., Christiansen, Stephen P., Crouch, Eric R., Enyedi, Laura B., Erzurum, S. Ayse, Everett, Donald F., Good, William V.

Get full text

Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of Prematurity by Crouch, Eric R, Kraker, Raymond T, Wallace, David K, Holmes, Jonathan M, Repka, Michael X, Collinge, Janine E, Bremer, Don L, Gray, Michael E, Smith, Heather A, Steinkuller, Paul G

“…Lower bevacizumab dosages are being used for type 1 retinopathy of prematurity, but there are limited data on long-term ocular outcomes with lower doses. To…”
Get more information

The Pediatric Optic Neuritis Prospective Outcomes Study by Pineles, Stacy L., Henderson, Robert J., Repka, Michael X., Heidary, Gena, Liu, Grant T., Waldman, Amy T., Borchert, Mark S., Khanna, Sangeeta, Graves, Jennifer S., Collinge, Janine E., Conley, Julie A., Davis, Patricia L., Kraker, Raymond T., Cotter, Susan A., Holmes, Jonathan M., Chang, Melinda Y., Contractor, Dilshad, Zolfaghari, Emily J., Vyas, Aarti, Yuen, Tiffany, Shah, Veeral S., Paysse, Evelyn A., Romany, Gihan, Peragallo, Jason H., Brower, Judy L., Raghuram, Aparna, Al Wattar, Bilal, Chinn, Ryan, Kothari, Srishti, Siatkowski, R. Michael, Lim, Maria E., Brewer, Alisha N., Doughty, Annette M., Icks, Sonny W., Almeida, Shannon, de Alba Campomanes, Alejandra, Banwait, Premilla, Hajkazemshirazi, Leila, Bastea-Forte, Yizhuo, Arjona, Jennifer K., Chen, Jeremy, Cooper, Karen, Ghadban, Rafif, Chung, Sophia M., Cruz, Oscar A., Christenson, Traci A., Breeding, Lisa L., Govreau, Dawn M., Wallis, Beth A., Geddie, Brooke E., Wolinski, Elisabeth T., Rudaitis, Indre M., Twite, Jacqueline, Bloomquist, Carrie S., Laboy, Sarah R., Twite, Jackie M., Doan, Michelle V., Bernardo, Marianne J., Brodsky, Michael C., Chen, John J., Wernimont, Suzanne M., Czaplewski, Lindsay L., Eastman, Stacy L., Keehn, Moriah A., Priebe, Debbie M., Bremer, Don L., Golden, Richard P., Jordan, Catherine O., McGregor, Mary Lou, Reem, Rachel E., Rogers, David L., Schreckengost, Amanda N., Maletic, Sara A., Dairi, Mays A., Enyedi, Laura B., Jones, Sarah K., Barman, Navajyoti R., House, Robert J., Nasrazadani, David A., Gratton, Sean M., Marsh, Justin D., Dent, Rebecca J., Bond, Lezlie L., Soske, Lori L., Sudhakar, Padmaja, Willen, Christi M., Taylor, Deborah, Moliterno, Nathaniel Q., Nsoesie, Michael, Vally, Shaista, Phillips, Paul H., Lowery, Robert S., Colon, Beth, Stotts, Nancy L., To, Kelly D., McClelland, Collin M., Areaux, Raymond G., Holleschau, Ann M., Merrill, Kim S., Ospina, Luis H.

Get full text

Two-year follow-up of the prospective outcomes study of pediatric optic neuritis by Pineles, Stacy L., Liu, Grant T., Wu, Rui, Kraker, Raymond T., Repka, Michael X., Heidary, Gena, Waldman, Amy T., Borchert, Mark S., Khanna, Sangeeta, Graves, Jennifer S., Collinge, Janine E., Conley, Julie A., Davis, Patricia L., Cotter, Susan A., Holmes, Jonathan M.

Get full text

A phase 1 dosing study of bevacizumab for ROP: 12-month ocular outcomes by Crouch, Eric R., Wallace, David K., Kraker, Raymond T., Repka, Michael X., Collinge, Janine E., Gray, Michael E., Steinkuller, Paul G., Bremer, Don L.

Get full text